KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Shares Outstanding (Weighted Average) (2016 - 2026)

Pacific Biosciences Of California has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $300.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 9.28% year-over-year to $300.0 million; the TTM value through Dec 2025 reached $300.0 million, up 9.28%, while the annual FY2025 figure was $300.0 million, 9.28% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $300.0 million at Pacific Biosciences Of California, roughly flat from $299.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $300.2 million in Q2 2025 and troughed at $11.2 million in Q3 2021.
  • A 5-year average of $239.2 million and a median of $249.9 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 93.28% in 2021 and later soared 1907.35% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $204.1 million in 2021, then grew by 10.0% to $224.6 million in 2022, then rose by 12.95% to $253.6 million in 2023, then rose by 8.22% to $274.5 million in 2024, then increased by 9.28% to $300.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PACB at $300.0 million in Q4 2025, $299.3 million in Q3 2025, and $300.2 million in Q2 2025.